ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors.

Eddy J Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.